I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research, development, and innovation has positioned him as a thought leader in the cell and gene therapy (CGT) industry. With a sharp focus on emerging technologies and strategic growth, Ivan
In a nation where millions of Americans ration life-saving medications due to staggering costs, and communities yearn for stable, high-paying jobs, one pharmaceutical giant is stepping up with a groundbreaking plan. AstraZeneca, a global leader in healthcare, has struck a historic agreement with
I'm thrilled to sit down with Ivan Kairatov, a renowned expert in biopharma with a wealth of experience in research and development, particularly in the rapidly evolving field of cell and gene therapies (CGTs). With his deep knowledge of technology and innovation in the industry, Ivan offers unique
Imagine a biopharmaceutical production line where every process, from drug formulation to final packaging, is mirrored in a virtual environment that predicts failures before they occur, optimizes workflows in real time, and slashes development costs by millions. This isn’t a distant dream but the
Imagine a region where the demand for life-changing biopharmaceuticals is skyrocketing, yet the race to deliver these treatments faster and more efficiently is becoming increasingly competitive. Asia, with its dynamic healthcare landscape, stands at the forefront of this challenge, particularly in
In the rapidly evolving realm of advanced therapy medicinal products (ATMPs) and complex biologics, the promise of transforming patient care is both exhilarating and daunting, as these cutting-edge treatments hold the potential to address some of the most pressing unmet medical needs, from rare
